Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0476089 (
endometrial cancer
)
11,379
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A patient with
endometrial cancer
presented with intracranial hemorrhage from an undiagnosed metastatic brain tumor during abdominal radical hysterectomy. Since she was neurologically intact, a systematic examination for brain metastasis had not been performed preoperatively. After the surgery, she had delayed recovery from general anesthesia with right hemiplegia and
aphasia
. Computed tomography and magnetic resonance imaging showed left putaminal hemorrhage from brain metastasis.
...
PMID:Intracranial hemorrhage from undiagnosed metastatic brain tumor during general anesthesia. 2205 Aug 1
Brain metastases from
endometrial carcinoma
are rare, however they do occur, and they are associated with an especially poor prognosis. There is evidence demonstrating improved outcomes with early diagnosis and subsequent multimodal treatment. This study therefore aims to review cases of brain metastases from
endometrial carcinoma
with specific focus on clinical presentation and disease history. This retrospective case series evaluated all cases of brain metastases from
endometrial carcinoma
at a single institution over a seven-year period. A medical records search was performed using ICD codes for
endometrial cancer
, brain lesions and brain imaging. Analysis of patient and disease characteristics was performed with descriptive statistics. Twelve cases were identified. The majority of cases had intermediate or high-grade histology (97.7%), advanced stage disease (58.3%), and at least one prior disease recurrence (66.7%). Eleven of 12 cases (91.7%) had lung metastases diagnosed prior to brain metastases. All 12 cases had neurologic signs and symptoms present at time of brain metastases diagnosis; 14 different types of neurologic deficits were noted. Headache was the most common neurologic symptom (5/12, 41.7%), followed by focal weakness (3/12, 25.0%) and
aphasia
(3/12, 25.0%). In conclusion, clinical presentation at time of diagnosis of brain metastases consistently includes neurologic signs and symptoms with persistent headache being the most common.
Endometrial cancer
patients that present with new neurologic complaints or exam findings should be evaluated for brain metastases.
...
PMID:Clinical presentation of brain metastases from endometrial carcinoma: A case series. 3096 86